Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-Wide Association Study of Brain Alzheimer's Disease-Related Metabolic Decline as Measured by [18F] FDG-PET Imaging.

Journal of Alzheimer's disease : JAD - 1 Jan 2020

Wang Rong-Ze, Yang Yu-Xiang, Li Hong-Qi, Shen Xue-Ning, Chen Shi-Dong, Dong Qiang, Wang Yi, Yu Jin-Tai

Abstract excerpt

BACKGROUND: Hypometabolism detected by fluorodeoxyglucose F18 positron emission tomography ([18F] FDG PET) is an early neuropathologic changes in Alzheimer's disease (AD) and provides important pathologic staging information. OBJECTIVE: This study aimed to discover genetic interactions that regulate longitudinal glucose metabolic decline in AD-related brain regions. METHODS: A total of 586 non-Hispanic white...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alzheimer Disease

Share to Cohort Studies

Share to Fluorodeoxyglucose F18

Share to Genome-Wide Association Study

Share to Positron-Emission Tomography

Source

Identifiers

PMID: 32804141
DOI: 10.3233/JAD-200415

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-Wide Association Study of Brain Alzheimer's Disease-Related Metabolic Decline as Measured by [18F] FDG-PET Imaging.PMID 32804141Read ↗

A variant in PPP4R3A protects against alzheimer-related metabolic decline.Semantic proximity Read ↗

Neuro-Metabolic and Vascular Dysfunction as an Early Diagnostic for Alzheimer’s Disease and Related DementiasSemantic proximity Read ↗

Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism.Semantic proximity Read ↗

Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.Semantic proximity Read ↗

Meta analysis of glucose metabolism across Alzheimer’s, Parkinson’s and ALS Reveals emergence of adaptive brain glucometabolic responses and associated neurological functional profilesSemantic proximity Read ↗

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.Semantic proximity Read ↗

Brain metabolic resilience conferred by the APOE3 Christchurch variant in autosomal dominant Alzheimer’s disease and across the adult lifespanSemantic proximity Read ↗

Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders.Semantic proximity Read ↗

Multiple genetic imaging study of the association between cholesterol metabolism and brain functional alterations in individuals with risk factors for Alzheimer's disease.Semantic proximity Read ↗

Elevated blood glucose levels are associated with the progression of brain hypometabolism, and HDL-C and<i>APOE4</i>add to this associationSemantic proximity Read ↗

Genome-wide association study identifies RBFOX1 locus influencing brain glucose metabolismSemantic proximity Read ↗

Glucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical Thinning.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.